Federal agencies lift pause on use of Johnson & Johnson vaccine, saying benefits outweigh risks

The U.S. decision to lift the pause on the vaccine’s use with a warning added to the label is similar to one taken by Europe’s drug regulator.

View original article
Contributor: Lena H. Sun